What is the LH ceiling level for follicular growth arrest in late follicular phase?
نویسندگان
چکیده
منابع مشابه
What clinical evidence for an LH ceiling?
trophins [OR 0.89 (95% CI 0.65±1.22)]. (Figure 2). In addition, recalculating the clinical pregnancy rate per cycle started after extracting the correct data from the paper of The European and Israeli Study Group on highly puri®ed hMG versus rFSH (2002) would result in OR 95% CI that reached unity, meaning that there is no statistically signi®cant difference between both types of gonadotrophins...
متن کاملO-26: Effects of Recombinant-LH Supplementation on The Proteomic Profile of Follicular Fluid from Poor Responder Patients: Focus on Follicular Growth Factors and Oocyte Maturity Markers
Background Poor and fragmentary data was available regarding the effects of recombinant-LH (r-LH) in in-vitro granulosa and theca cells of human origin. No data was available from in vivo studies regarding the effects of r-LH supplementation on SCF,EGF,ERK-1/2 and AKT-1 pathways in the follicular fluid of older-poor-responder women undergoing IVF cycle. Evidence from in-vitro and animal studies...
متن کاملEstrogen and LH Dynamics During the Follicular Phase of the Estrous Cycle in the Asian Elephant
Pituitary and corpus luteum hormone patterns throughout the elephant estrous cycle have been well characterized. By contrast, analysis of follicular maturation by measurement of circulating estrogens has been uninformative. This study tested the ability of a urinary estradiol-3-glucuronide radioimmunoassay to noninvasively assess follicular development during the nonluteal phase of the elephant...
متن کاملWhat is the role of maintenance rituximab in follicular NHL?
Recent trials have demonstrated improvements in progression-free and overall survival with the inclusion of the chimeric anti-CD20 monoclonal antibody rituximab (Rituxan) in chemotherapy regimens for treatment-naive and relapsed patients with advanced-stage follicular non-Hodgkin's lymphoma (NHL). As rituximab therapy has significant single-agent activity infollicular NHL, is generally well tol...
متن کاملClinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation.
BACKGROUND The objective of these studies was to test the hypothesis that over-dosing with recombinant human LH (rLH) during the late follicular phase would suppress the development of follicles. METHODS Two double-blind studies were conducted. In study A, WHO I anovulatory patients received treatment with rFSH and rLH. When at least one follicle reached a mean diameter of 10-13 mm, patients ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Reproduction
سال: 2004
ISSN: 1460-2350
DOI: 10.1093/humrep/deh076